Stockreport

Ocular Therapeutix Touts Landmark Phase 3 AXPAXLI Win at RBC Ophthalmology Conference [Yahoo! Finance]

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com
PDF plans to file for FDA approval based on SOL-1 alone , while the second Phase 3 trial SOLAR is ongoing with a readout expected in Q1 next year. Management says the repo [Read more]